ArticleOpen forum infectious diseases2025
What Is the Optimal Community-Based Tuberculosis Screening Algorithm for People Who Inject Drugs in a High-Burden Setting?
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although people who inject drugs (PWID) are a high-risk group for tuberculosis (TB), current case-finding strategies fail to identify most TB cases. There is a need for an optimized community-based algorithm to improve TB detection in such disproportionately affected populations. Methods: Using respondent-driven sampling, we recruited PWID at community sites in Hai Phong, Vietnam, screening for classic TB symptoms, C-reactive protein blood measurement, portable on-site chest x-ray with CAD4TB software (Computer-Aided Detection for Tuberculosis version 7; Delft Imaging Systems BV), and Xpert MTB/RIF on sputum. Any participants suspected of TB by on-site physicians were referred to the infectious disease hospital for confirmatory testing, and external experts validated final diagnoses, which were then used as the TB gold standard. We aimed to identify the screening algorithm with the highest case detection at the lowest cost among different on-site testing combinations. Ingredients-based costing was used to evaluate the cost per test and cost per case detected for each algorithm. Results: Among the 1080 PWID enrolled, 47 (4.4%; 95% CI, 2.8%-6.4%) were diagnosed with TB disease. When compared with the current symptom-based TB screening strategy in Vietnam (double D), systematic chest x-ray with CAD4TB, Xpert MTB/RIF for those with CAD4TB ≥50, and referral to care for those with either CAD4TB ≥70 or a positive Xpert test result doubled the sensitivity (82.9% vs 43.9%) and yield (3.2% vs 1.7%) while maintaining a reasonable cost per TB case detected (US $439 vs $309 for standard of care). Conclusions: We defined an acceptable and moderate cost algorithm that improves efficiency for community-based TB screening among PWID in Vietnam. To reflect real TB prevalence, we make the case that active case finding and systematic screening strategies should not limit testing to those with a positive symptom screen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.